Group A streptococcus (GAS) pharyngitis, also known as strep throat, is a bacterial infection that occurs at the back of throat, including the tonsils. It is common among young infants and adult geriatric population, and occurs majorly at the end of winter season. Common symptoms associated with the infection include fever, sore throat, abdominal pain, nausea, vomiting, red eyes, and diarrhea. Strep throat is a communicable disease caused as a result of exposure with an infected person. Therefore, places with high footfall such as schools and military academies are likely to witness most transmission. Traditional diagnostic include a throat culture with a higher sensitivity and a rapid strep test, which comes with the advantage of quick results.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of the COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Owing to such factors, COVID 19 is expected to have a significant impact on the GAS pharyngitis diagnostics market.
Top Impacting Factors
- Increase in the number of death incidents due to rheumatic heart disease especially in industrialized regions is anticipated to drive market growth. The disease is caused by exposure to group A streptococcus bacteria, which leads to scarlet fever and strep throat.
- Significant grassroots work being carried out in diagnostics industry coupled with an influx of foreign direct investments and robust governmental policies is further promising great results for GAS pharyngitis market.
- Rising awareness with respect to new age diagnostic techniques launched and still under design & development phase coupled with consumer shift toward advanced healthcare mechanisms from the traditional means is likely to provide much required impetus for the growth of GAS pharyngitis diagnostic market. Countries with robust purchasing power parity and favorable reimbursements are most likely to experience consumer shifts.
- However, the market is likely to be hampered, owing to wide array of challenges associated with GA pharyngitis diagnosis. Among them, providing accurate, specific, and efficient diagnostic results is of the foremost importance.
- Additionally, lack of awareness on recently developed diagnostic techniques coupled with wide spectrum of misconceptions rumored in third world economies and regions with disturbed politico-legal dynamics may hamper the market penetration.
- Shift of total healthcare infrastructure toward battling COVID-19 and its effects have resulted in delays in new diagnostic product launches and cancellations in clinical trials. This may further hamper current growth of GAS pharyngitis diagnostic kits market.
Key Market Trends
- North America is anticipated to witness dominance in GAS pharyngitis diagnostic kit market, owing to large number of recent incidents of the disease being reported in the region coupled with policy shift toward quick design and development of new age therapeutic/diagnostic mechanisms.
- Doctors and Researchers at Saint Michael’s Medical Center are studying new cased of co-occurrence of GAS pharyngitis and COVID-19 being reported in the U.S. Increasing number of cases of COVID-19 patients suffering from upper respiratory disorders are being reported simultaneously in the region which are of great concern to the healthcare industry.
- Clinical labs around the globe are working on the prospect of assimilating molecular assays to eliminate the need for supplement testing.
Key Benefits of the Report
- This study presents the analytical depiction of the GAS pharyngitis diagnostics industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the GAS pharyngitis diagnostics market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the GAS Pharyngitis Diagnostics Report
- Which are the leading players active in the GAS pharyngitis diagnostics market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the GAS pharyngitis diagnostics market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is GAS pharyngitis diagnostics?
- What is the GAS pharyngitis diagnostics market prediction in the future?
- What are the current trends and predicted trends?
GAS Pharyngitis Diagnostics Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., Meridian Bioscience, Inc., Beckman Coulter, Inc. (Danaher), Abbott Laboratories, BD, Quidel Corporatiion, Multibrands International Ltd., Sekisui Diagnostics, Mckesson CONSULT |
Loading Table Of Content...
